MSO Structures in Healthcare: The Hidden Corporate Practice of Medicine Risks That Derail Growth and Investment
A healthcare startup scales through a Management Services Organization (MSO) model. Investors control operations, branding, and revenue streams. Physicians technically own the clinical entity.
On paper, compliance exists.
In practice, regulators scrutinize control, compensation, and fee arrangements under corporate practice of medicine (CPOM) doctrines.
Corporate Practice of Medicine: The Structural Constraint
Many states prohibit non-physicians from owning or controlling medical practices.
To work around this, healthcare groups commonly use:
A physician-owned Professional Corporation (PC) or Professional Limited Liability Company (PLLC)
A separate MSO owned by investors
A Management Services Agreement (MSA)
The MSO provides administrative services in exchange for fees.
However, structure alone does not ensure compliance.
Where MSO Models Break Down
Regulators evaluate substance over form.
Red flags include:
MSO control over clinical decision-making.
Compensation formulas tied directly to clinical revenue percentages.
Termination provisions that effectively remove physician independence.
Restrictive covenants that undermine physician autonomy.
De facto ownership through stock transfer restrictions.
Fee-splitting prohibitions also restrict revenue-sharing tied to professional fees.
Compensation Structures: Fixed Fee vs. Percentage Models
Percentage-based MSO fees tied to gross revenue are common—but risky in certain jurisdictions.
Alternative approaches:
Fair market value fixed fees.
Cost-plus models.
Tiered service pricing tied to objective metrics.
Healthcare valuations and compliance opinions often require third-party FMV assessments to mitigate enforcement risk under state laws and federal Anti-Kickback Statute implications when federal payors are involved.
Investor Due Diligence Focus Areas
Healthcare investors assess:
CPOM compliance opinion letters.
Fair market value analyses.
MSA termination and assignment provisions.
Control rights embedded in governance.
Physician employment and restrictive covenant enforceability.
Billing compliance infrastructure.
A poorly structured MSO reduces exit optionality and deters sophisticated capital.
Enforcement and Civil Exposure
Risk exposure includes:
State attorney general investigations.
Medical board actions.
Contract unenforceability.
Recoupment demands.
Private whistleblower actions.
Federal scrutiny if reimbursement programs are implicated.
Structural defects often surface during expansion or sale—not formation.
MSO Compliance Review Checklist
Healthcare founders and operators should:
Analyze applicable CPOM doctrine in operating states.
Review governance documents for hidden control triggers.
Conduct fair market value assessment of management fees.
Stress-test termination and buyout provisions.
Ensure clinical autonomy documentation.
Audit compensation for fee-splitting risk.
Integrate healthcare regulatory counsel into expansion planning.
Growth without structural compliance can unravel enterprise value.
Final Thought
Healthcare innovation attracts capital—but it operates within rigid statutory frameworks.
An MSO model is not just a workaround. It is a regulated architecture that must withstand scrutiny from regulators, investors, and acquirers.
If you are structuring or expanding a healthcare MSO, contact StartSmart Counsel PLLC at 786.461.1617 to schedule a consultation. This article is informational and not legal advice.
